# Spire Inc: financial statements, quarterly

SR · NYSE · CIK 1126956 · [Utilities](/sectors/utilities.md) · fiscal year ends Sep 30

Pages: [Overview](/companies/sr.md) · [Financials](/companies/sr/financials.md) · [Filings](/companies/sr/filings.md) · [Insiders](/companies/sr/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sr/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-06-30) | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [419](/filings/0001437749-24-024001.md) | [310 d](/filings/0001193125-25-282583.md) | [757](/filings/0000950170-25-014213.md) | [1,129](/filings/0000950170-25-060698.md) | [414](/filings/0000950170-25-102597.md) | [294 d](/filings/0001193125-25-282583.md) | [669](/filings/0001193125-26-034779.md) | [1,051](/filings/0000950170-25-060698.md) | [422](/filings/0000950170-25-102597.md) | [334 d](/filings/0001193125-25-282583.md) | [762](/filings/0001193125-26-034779.md) | not reported |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | [297](/filings/0001193125-26-034779.md) | not reported | not reported | not reported | [343](/filings/0001193125-26-034779.md) | not reported |
| Operating income | $m | [12.0](/filings/0001437749-24-024001.md) | [(3.9) d](/filings/0001193125-25-282583.md) | [139](/filings/0000950170-25-014213.md) | [299](/filings/0000950170-25-060698.md) | [30.7](/filings/0000950170-25-102597.md) | [19.8 d](/filings/0001193125-25-282583.md) | [149](/filings/0001193125-26-034779.md) | [278](/filings/0001193125-26-208452.md) | [69.2](/filings/0000950170-25-102597.md) | [(0.5) d](/filings/0001193125-25-282583.md) | [174](/filings/0001193125-26-034779.md) | [304](/filings/0001193125-26-208452.md) |
| Interest expense | $m | [46.7](/filings/0001437749-24-024001.md) | [48.2 d](/filings/0001193125-25-282583.md) | [50.6](/filings/0000950170-25-014213.md) | [52.2](/filings/0000950170-25-060698.md) | [48.8](/filings/0000950170-25-102597.md) | [49.5 d](/filings/0001193125-25-282583.md) | [48.0](/filings/0001193125-26-034779.md) | [45.3](/filings/0001193125-26-208452.md) | [49.9](/filings/0000950170-25-102597.md) | [58.8 d](/filings/0001193125-25-282583.md) | [60.4](/filings/0001193125-26-034779.md) | [62.6](/filings/0001193125-26-208452.md) |
| Income tax | $m | [(6.8)](/filings/0001437749-24-024001.md) | [(16.9) d](/filings/0001193125-25-282583.md) | [21.0](/filings/0000950170-25-014213.md) | [49.4](/filings/0000950170-25-060698.md) | [(3.1)](/filings/0000950170-25-102597.md) | [(8.6) d](/filings/0001193125-25-282583.md) | [20.1](/filings/0001193125-26-034779.md) | [46.3](/filings/0001193125-26-208452.md) | [3.0](/filings/0000950170-25-102597.md) | [(16.1) d](/filings/0001193125-25-282583.md) | [23.4](/filings/0001193125-26-034779.md) | [52.7](/filings/0001193125-26-208452.md) |
| Net income | $m | [(21.6)](/filings/0001437749-24-024001.md) | [(31.1) d](/filings/0001193125-25-282583.md) | [85.1](/filings/0000950170-25-014213.md) | [204](/filings/0000950170-25-060698.md) | [(12.6)](/filings/0000950170-25-102597.md) | [(25.9) d](/filings/0001193125-25-282583.md) | [81.3](/filings/0001193125-26-034779.md) | [209](/filings/0001193125-26-208452.md) | [20.9](/filings/0000950170-25-102597.md) | [(39.8) d](/filings/0001193125-25-282583.md) | [95.0](/filings/0001193125-26-034779.md) | [282](/filings/0001193125-26-208452.md) |
| Diluted EPS | $ per share | [(0.48)](/filings/0001437749-24-024001.md) | not reported | [1.52](/filings/0000950170-25-014213.md) | [3.58](/filings/0000950170-25-060698.md) | [(0.28)](/filings/0000950170-25-102597.md) | not reported | [1.34](/filings/0001193125-26-034779.md) | [3.51](/filings/0001193125-26-208452.md) | [0.29](/filings/0000950170-25-102597.md) | not reported | [1.54](/filings/0001193125-26-034779.md) | [4.60](/filings/0001193125-26-208452.md) |
| Basic EPS | $ per share | [(0.48)](/filings/0001437749-24-024001.md) | not reported | [1.52](/filings/0000950170-25-014213.md) | [3.59](/filings/0000950170-25-060698.md) | [(0.28)](/filings/0000950170-25-102597.md) | not reported | [1.34](/filings/0001193125-26-034779.md) | [3.52](/filings/0001193125-26-208452.md) | [0.29](/filings/0000950170-25-102597.md) | not reported | [1.55](/filings/0001193125-26-034779.md) | [4.61](/filings/0001193125-26-208452.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-06-30) | FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [0.0](/filings/0001437749-24-024001.md) | [0.0](/filings/0001437749-24-035823.md) | [0.0](/filings/0000950170-25-014213.md) | [0.0](/filings/0000950170-25-060698.md) | [0.0](/filings/0000950170-25-102597.md) | [0.0](/filings/0001193125-25-282583.md) | [0.0](/filings/0001193125-26-034779.md) | [0.0](/filings/0001193125-26-208452.md) | [0.0](/filings/0000950170-25-102597.md) | [0.0](/filings/0001193125-26-208452.md) | [0.0](/filings/0001193125-26-034779.md) | [0.0](/filings/0001193125-26-208452.md) |
| Current assets | $bn | [0.9](/filings/0001437749-24-024001.md) | [1.1](/filings/0001437749-24-035823.md) | [1.2](/filings/0000950170-25-014213.md) | [1.0](/filings/0000950170-25-060698.md) | [0.8](/filings/0000950170-25-102597.md) | [0.8](/filings/0001193125-25-282583.md) | [1.0](/filings/0001193125-26-034779.md) | [0.9](/filings/0001193125-26-208452.md) | [0.8](/filings/0000950170-25-102597.md) | [0.8](/filings/0001193125-26-208452.md) | [1.0](/filings/0001193125-26-034779.md) | [1.6](/filings/0001193125-26-208452.md) |
| Total assets | $bn | [10.0](/filings/0001437749-24-024001.md) | [10.3](/filings/0001437749-24-035823.md) | [10.6](/filings/0000950170-25-014213.md) | [10.7](/filings/0000950170-25-060698.md) | [10.7](/filings/0000950170-25-102597.md) | [10.9](/filings/0001193125-25-282583.md) | [11.3](/filings/0001193125-26-034779.md) | [11.3](/filings/0001193125-26-208452.md) | [11.4](/filings/0000950170-25-102597.md) | [11.6](/filings/0001193125-26-208452.md) | [11.9](/filings/0001193125-26-034779.md) | [14.7](/filings/0001193125-26-208452.md) |
| Current liabilities | $bn | [1.5](/filings/0001437749-24-024001.md) | [1.8](/filings/0001437749-24-035823.md) | [2.2](/filings/0000950170-25-014213.md) | [1.7](/filings/0000950170-25-060698.md) | [1.7](/filings/0000950170-25-102597.md) | [1.7](/filings/0001193125-25-282583.md) | [2.0](/filings/0001193125-26-034779.md) | [2.1](/filings/0001193125-26-208452.md) | [2.1](/filings/0000950170-25-102597.md) | [2.5](/filings/0001193125-26-208452.md) | [1.7](/filings/0001193125-26-034779.md) | [2.9](/filings/0001193125-26-208452.md) |
| Long-term debt | $bn | [3.6](/filings/0001437749-24-024001.md) | [3.6](/filings/0001437749-24-035823.md) | [3.2](/filings/0000950170-25-014213.md) | [3.4](/filings/0000950170-25-060698.md) | [3.4](/filings/0000950170-25-102597.md) | [3.7](/filings/0001193125-25-282583.md) | [3.7](/filings/0001193125-26-034779.md) | [3.3](/filings/0001193125-26-208452.md) | [3.5](/filings/0000950170-25-102597.md) | [3.4](/filings/0001193125-26-208452.md) | [4.4](/filings/0001193125-26-034779.md) | [5.8](/filings/0001193125-26-208452.md) |
| Current portion of debt | $bn | not reported | [0.2](/filings/0001437749-24-035823.md) | not reported | not reported | not reported | [0.0](/filings/0001193125-25-282583.md) | not reported | not reported | not reported | [0.5](/filings/0001193125-25-282583.md) | not reported | not reported |
| Short-term borrowings | $bn | [0.6](/filings/0001437749-24-024001.md) | [1.0](/filings/0001437749-24-035823.md) | [1.0](/filings/0000950170-25-014213.md) | [0.8](/filings/0000950170-25-060698.md) | [0.8](/filings/0000950170-25-102597.md) | [0.9](/filings/0001193125-25-282583.md) | [1.2](/filings/0001193125-26-034779.md) | [1.0](/filings/0001193125-26-208452.md) | [1.0](/filings/0000950170-25-102597.md) | [1.3](/filings/0001193125-26-208452.md) | [0.4](/filings/0001193125-26-034779.md) | [2.0](/filings/0001193125-26-208452.md) |
| Shareholders' equity | $bn | [2.9](/filings/0001437749-24-024001.md) | [2.9](/filings/0001193125-25-282583.md) | [3.1](/filings/0000950170-25-060698.md) | [3.4](/filings/0000950170-25-102597.md) | [3.3](/filings/0000950170-25-102597.md) | [3.2](/filings/0001193125-26-208452.md) | [3.3](/filings/0001193125-26-208452.md) | [3.5](/filings/0001193125-26-208452.md) | [3.5](/filings/0000950170-25-102597.md) | [3.4](/filings/0001193125-26-208452.md) | [3.4](/filings/0001193125-26-208452.md) | [3.4](/filings/0001193125-26-208452.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-06-30) | Q4 FY2023 (2023-09-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q4 FY2024 (2024-09-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q4 FY2025 (2025-09-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [224 d](/filings/0001437749-24-024001.md) | [36.1 d](/filings/0001193125-25-282583.md) | [70.0](/filings/0000950170-25-014213.md) | [489 d](/filings/0000950170-25-060698.md) | [270 d](/filings/0000950170-25-102597.md) | [82.9 d](/filings/0001193125-25-282583.md) | [81.1](/filings/0001193125-26-034779.md) | [373 d](/filings/0001193125-26-208452.md) | [129 d](/filings/0000950170-25-102597.md) | [(4.9) d](/filings/0001193125-25-282583.md) | [81.0](/filings/0001193125-26-034779.md) | [410 d](/filings/0001193125-26-208452.md) |
| Capital expenditure | $m | [176](/filings/0001437749-24-024001.md) | [179 d](/filings/0001193125-25-282583.md) | [227](/filings/0000950170-25-014213.md) | [183](/filings/0000950170-25-060698.md) | [222](/filings/0000950170-25-102597.md) | [230 d](/filings/0001193125-25-282583.md) | [261](/filings/0001193125-26-034779.md) | [219](/filings/0000950170-25-060698.md) | [221](/filings/0000950170-25-102597.md) | [223 d](/filings/0001193125-25-282583.md) | [203](/filings/0001193125-26-034779.md) | [192 d](/filings/0001193125-26-208452.md) |
| Dividends paid | $m | [38.0 d](/filings/0001437749-24-024001.md) | [38.2 d](/filings/0001193125-25-282583.md) | [38.8](/filings/0000950170-25-014213.md) | [41.7 d](/filings/0000950170-25-060698.md) | [43.8 d](/filings/0000950170-25-102597.md) | [42.8 d](/filings/0001193125-25-282583.md) | [44.6](/filings/0001193125-26-034779.md) | [45.4 d](/filings/0001193125-26-208452.md) | [45.8 d](/filings/0000950170-25-102597.md) | [46.4 d](/filings/0001193125-25-282583.md) | [47.2](/filings/0001193125-26-034779.md) | [48.9 d](/filings/0001193125-26-208452.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets, us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q4 FY2022 (2022-09-30) | Q1 FY2023 (2022-12-31) | Q2 FY2023 (2023-03-31) | Q3 FY2023 (2023-06-30) | Q1 FY2024 (2023-12-31) | Q2 FY2024 (2024-03-31) | Q3 FY2024 (2024-06-30) | Q1 FY2025 (2024-12-31) | Q2 FY2025 (2025-03-31) | Q3 FY2025 (2025-06-30) | Q1 FY2026 (2025-12-31) | Q2 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [52.6](/filings/0001437749-23-002213.md) | [52.6](/filings/0001437749-24-002776.md) | [52.6](/filings/0001437749-24-014087.md) | [52.5](/filings/0001437749-24-024001.md) | [53.6](/filings/0000950170-25-014213.md) | [55.9](/filings/0000950170-25-060698.md) | [57.7](/filings/0000950170-25-102597.md) | [57.9](/filings/0001193125-26-034779.md) | [58.5](/filings/0001193125-26-208452.md) | [59.1](/filings/0000950170-25-102597.md) | [59.2](/filings/0001193125-26-034779.md) | [59.2](/filings/0001193125-26-208452.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 59,116,792 at 2026-04-29, from the cover of the [10-Q filed 2026-05-06](/filings/0001193125-26-208452.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.